Title

Dasatinib-Induced Chylothorax in Chronic Myeloid Leukemia

Document Type

Article

Department

Internal Medicine (East Africa)

Abstract

Pulmonary adverse events are common abnormalities associated with the use of dasatinib in chronic myeloid leukemia. We present a case of a 69-year-old man who suddenly developed a rare chylothorax pulmonary adverse event following 10 months of dasatinib treatment.

Publication

Baylor University Medical Center Proceedings

Share

COinS